Fluoxetine as a treatment for post‐stroke emotionalism

  title={Fluoxetine as a treatment for post‐stroke emotionalism},
  author={K. W. Brown and R L Sloan and Brian T. Pentland},
  journal={Acta Psychiatrica Scandinavica},
The effectiveness of fluoxetine compared to placebo in the treatment of post‐stroke emotionalism was investigated in 20 patients using a double‐blind protocol. A total of 19 patients completed the study, as one subject in the treatment group had to be withdrawn. The subjects receiving fluoxetine showed a statistically and clinically significant improvement in their emotionalism compared to the placebo group, which was apparent in the majority of subjects from the third day of treatment. 

Fluoxetine Treatment in Poststroke Depression, Emotional Incontinence, and Anger Proneness: A Double-Blind, Placebo-Controlled Study

Fluoxetine significantly improved PSEI and PSAP, whereas no definitive improvement of PSD was found and its effect on PSD is not solidly confirmed.

Selective serotonine reuptake inhibitors prevents emotional lability in healthy subjects.

The antidepressant drugs of the family of selective serotonine reuptake inhibitors (SSRI) improve EL within a few days in both depressive and neurological disorders.

SSRIs for Post-Stroke Emotionalism

Post-stroke emotionalism occurs in up to 20% of patients after a cerebrovascular event and is relatively benign emotive or neutral social in this syndrome.

Associations of serotonergic genes with poststroke emotional incontinence

Polymorphisms of serotonin transporter and serotonin 2a receptor genes may regulate serotonergic signaling at brain synapses, and associations with PSEI in an East Asian population are investigated.

Treatment of psychiatric syndromes due to cerebrovascular disease

Treatment principles are broadly similar to those currently used to treat non-organically ill patients and future studies might include multi-modal interventions using the principles of active case management and pharmacological studies which target both specific neuropsychiatric symptoms and underlying cerebrovascular disorder.

Serotonin and stroke

Selective Serotonin Reuptake Inhibitors for Stroke Recovery.

A meta-analysis of all (published and unpublished) randomized controlled trials of SSRI compared with control, given within the first year of stroke, to determine the effect on dependency, disability, and other important clinical outcomes.

Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms

The phenomenology, factors or predictors, and relevant lesion locations will be described, and pharmacological treatment of these emotional disturbances will be discussed based on presumable pathophysiological mechanisms.

Post-Stroke Depression and Mood Disorders

This chapter explores the evidence regarding interventions for the prevention and treatment of post-stroke depression, as well as its prevalence, predictors, and consequences.

Lamotrigine treatment for post-stroke pathological laughing and crying.

A 60-year-old woman developed PLC after an ischemic stroke and was treated with lamotrigine initially at the dose of 50mg a day, which was gradually increased to 100 mg a day over a 4-week period, showing a significant and rapid recovery in both laughing and crying components of PCL with lamOTrigine treatment.



Fluoxetine as a treatment for emotional lability after brain injury.

An open trial using fluoxetine, a newer antidepressant with a specific serotonergic action, in the treatment of emotional lability due to brain injury and the drug was well tolerated with no reported side-effects.

Citalopram for post-stroke pathological crying

Mood Disorders in the Year after First Stroke

While there was a high cumulative incidence of psychiatric disorder, little of it persisted: only two cases of major depression were present for the whole 12 months and undue emphasis has been placed on major depression as a specific syndrome following stroke.

Treatment of pathologic laughing and weeping with amitriptyline.

It is concluded that amitriptyline is effective in the treatment of this disturbance of affective expression, and that this effect is distinct from the antidepressant effect of the medication.

The Use of Imipramine (“Tofranil”) and Other Psychotropic Drugs in Organic Emotionalism

A “double-blind” form of therapeutic trial was engaged, comparing two dose strengths of imipramine with phenobarbitone and dummy tablets given in random sequence to each patient, confirming the favourable impression of imIPramine being confirmed and attempting to assess the effect on this symptom of two other drugs of related pharmacology.

Pharmacologic treatment of emotional lability.

The experience with fluvoxamine, a selective serotonin reuptake inhibitor, used to treat 10 patients with emotional incontinence suggests that the serotoninergic system may be implicated in emotional lability.

Emotionalism after stroke.

Emotionalism is common after stroke and is associated with symptoms of a more general mood disturbance and is found especially in patients with left frontal and temporal lesions.

Fluoxetine improves emotional incontinence.

The efficacy of fluoxetine was investigated in 13 patients with emotional incontinence and all 13 patients demonstrated dramatic improvement in emotional lability within 3 to 14 days.

Pathological crying and laughing: treatment with sertraline.

Pathologic laughing and crying treated with levodopa.

Because part of pathologic laughing and crying seems to be caused by the decreased function of the dopaminergic neuron, levodopa or amantadine is worth trying.